Tatva Chintan Pharma Chem has informed that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 to consider and approve and take on record the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31 December 2024. Further, in accordance with the Company's Code of Conduct for Prohibition of Insider Trading, the Company has intimated its 'designated persons' regarding the closure of the Trading Window for trading in the Company's equity shares from 01 January 2025 till the expiry of 48 hours from the date the said financial results are made public. The above information is also being made available on the website of the Company at www.tatvachintan.com
The above information is a part of company’s filings submitted to BSE.
